Image of Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Mycoplasma pulmonis-host relationships in a breeding colony of Sprague-Dawley rats with enzootic murine respiratory mycoplasmosis.
Authors: Authors: Lindsey JR, Davidson MK, Schoeb TR, Cassell GH.
Lab Anim Sci
View full abstract on Pubmed
Nonspecific lymphocyte responses in F344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences.
Authors: Authors: Davis JK, Simecka JW, Williamson JS, Ross SE, Juliana MM, Thorp RB, Cassell GH.
Infect Immun
View full abstract on Pubmed
Ureaplasma urealyticum polyarthritis in agammaglobulinemia.
Authors: Authors: Vogler LB, Waites KB, Wright PF, Perrin JM, Cassell GH.
Pediatr Infect Dis
View full abstract on Pubmed
Clinically silent polymicrobial amnionitis and intrauterine fetal death associated with a Cu-7 intrauterine contraceptive device.
Authors: Authors: Waites KB, Bobo RA, Davis RO, Brookings ES, Cassell GH.
Am J Obstet Gynecol
View full abstract on Pubmed
A prospective study of mycoplasma infection in the preterm infant.
Authors: Authors: Rudd PT, Brown MB, Cassell GH.
Isr J Med Sci
View full abstract on Pubmed
Mycoplasma pulmonis detection in rodents: lessons for diagnosis in other species.
Authors: Authors: Cassell GH, Davis JK, Cox NR, Davidson MK, Lindsey JR.
Isr J Med Sci
View full abstract on Pubmed
Multiphasic interactions of Mycoplasma pulmonis with erythrocytes defined by adherence and hemagglutination.
Authors: Authors: Minion FC, Cassell GH, Pnini S, Kahane I.
Infect Immun
View full abstract on Pubmed
Immunoglobulin A1 protease activity in strains of Ureaplasma urealyticum.
Authors: Authors: Kilian M, Brown MB, Brown TA, Freundt EA, Cassell GH.
Acta Pathol Microbiol Immunol Scand B
View full abstract on Pubmed
Identification of cross-reactive antigens between Mycoplasma pulmonis and Mycoplasma arthritidis.
Authors: Authors: Minion FC, Brown MB, Cassell GH.
Infect Immun
View full abstract on Pubmed
Microbiologic study of infertile women at the time of diagnostic laparoscopy. Association of Ureaplasma urealyticum with a defined subpopulation.
Authors: Authors: Cassell GH, Younger JB, Brown MB, Blackwell RE, Davis JK, Marriott P, Stagno S.
N Engl J Med
View full abstract on Pubmed